Hillhouse Capital Advisors »

Maze Therapeatics shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 458k 25.93
2025-06-30 $5.6M 458k 12.27
2025-03-31 $5.0M 458k 11.01

More positions owned by Hillhouse Capital Advisors

Pdd Holdings Sponsored Ads (PDD)
Alibaba Group Hldg Sponsored Ads (BABA)
Futu Hldgs Spon Ads Cl A (FUTU)
Webull Corp Ord Shs (BULL)
Beone Medicines Sponsored Ads (ONC)
Baidu Spon Adr Rep A (BIDU)
Legend Biotech Corp Sponsored Ads (LEGN)
Netease Sponsored Ads (NTES)
Arrivent Biopharma (AVBP)
Ke Hldgs Sponsored Ads (BEKE)
Full Truck Alliance Sponsored Ads (YMM)
Yatsen Hldg Sponsored Ads (YSG)
Sea Sponsord Ads (SE)
Clearwater Analytics Hldgs I Cl A (CWAN)
Cytek Biosciences (CTKB)

View all positions for Hillhouse Capital Advisors

Top funds holding Maze Therapeatics

Trv Gp Iv
Frazier Life Sciences Management
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Matrix Capital Management Company
Vanguard Group
BlackRock
VR Adviser
Logos Global Management
General Catalyst Group Management
Woodline Partners
TRV GP V
Marshall Wace

View all funds holding Maze Therapeatics